Technology
Health
Pharmaceutical

Gritstone Oncology

$12.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
+$0.58 (5.07%) After Hours

Why Robinhood?

You can buy or sell GRTS and other stocks, options, ETFs, and crypto commission-free!

About

Gritstone Oncology, Inc. provides cancer immunotherapy therapeutics services. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria and is headquartered in Emeryville, CA.

Employees
88
Headquarters
Emeryville, California
Founded
2015
Market Cap
28.51M
Price-Earnings Ratio
Dividend Yield
Average Volume
159.33K
High Today
$11.72
Low Today
$11.22
Open Price
$11.35
Volume
74.15K
52 Week High
$32.90
52 Week Low
$9.66

Collections

Technology
Health
Pharmaceutical
Cancer Prevention
Therapy
2018 IPO
US
North America

Earnings

-$7.60
-$5.26
-$2.93
-$0.59
Q3 2018
Q4 2018
Estimated
-$0.65 per share
Actual
Expected Mar 26, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.